BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee DH, Lee JM. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?: Whole-Body PET/MRI for Colorectal Cancer. J Magn Reson Imaging 2017;45:21-35. [DOI: 10.1002/jmri.25337] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Zheng D, Liu JJ, Cui JX, Xi HQ, Zhang KC, Huang XH, Wei B, Wang XX, Xu BX, Li K, Gao YH, Liang WQ, Tian JH, Chen L. Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer. Gastroenterol Res Pract 2019;2019:9564627. [PMID: 30863443 DOI: 10.1155/2019/9564627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cuda TJ, He Y, Kryza T, Khan T, Tse BW, Sokolowski KA, Liu C, Lyons N, Gough M, Snell CE, Wyld DK, Rose S, Riddell AD, Stevenson ARL, Thomas PA, Clark DA, Puttick S, Hooper JD. Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer. Contrast Media Mol Imaging 2021;2021:3153278. [PMID: 34621145 DOI: 10.1155/2021/3153278] [Reference Citation Analysis]
3 Li Y, Xin J, Sun Y, Han T, Zhang H, An F. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer. Cancer Biol Med 2020;17:307-27. [PMID: 32587771 DOI: 10.20892/j.issn.2095-3941.2020.0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Yoon JH, Lee JM, Chang W, Kang HJ, Bandos A, Lim HJ, Kang SY, Kang KW, Ryoo SB, Jeong SY, Park KJ. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT. Radiology 2020;294:310-9. [PMID: 31793850 DOI: 10.1148/radiol.2019190794] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Sivesgaard K, Larsen LP, Sørensen M, Kramer S, Schlander S, Amanavicius N, Mortensen FV, Pedersen EM. Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases. Acta Radiol 2020;61:156-67. [PMID: 31189329 DOI: 10.1177/0284185119855184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 García-Figueiras R, Baleato-González S, Padhani AR, Luna-Alcalá A, Marhuenda A, Vilanova JC, Osorio-Vázquez I, Martínez-de-Alegría A, Gómez-Caamaño A. Advanced Imaging Techniques in Evaluation of Colorectal Cancer. Radiographics 2018;38:740-65. [PMID: 29676964 DOI: 10.1148/rg.2018170044] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
7 Rutegård MK, Båtsman M, Blomqvist L, Rutegård M, Axelsson J, Ljuslinder I, Rutegård J, Palmqvist R, Brännström F, Brynolfsson P, Riklund K. Rectal cancer: a methodological approach to matching PET/MRI to histopathology. Cancer Imaging 2020;20:80. [PMID: 33129352 DOI: 10.1186/s40644-020-00347-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Crimì F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, Zucchetta P, Pucciarelli S, Pomerri F. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience. Dis Colon Rectum 2020;63:310-8. [PMID: 31842163 DOI: 10.1097/DCR.0000000000001568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Belmouhand M, Löfgren J, Johannesen HH, Baeksgaard L, Gutte H, Tariq K, Achiam MP. Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction. Abdom Radiol (NY) 2019;44:836-44. [PMID: 30467723 DOI: 10.1007/s00261-018-1841-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rutegård MK, Båtsman M, Axelsson J, Brynolfsson P, Brännström F, Rutegård J, Ljuslinder I, Blomqvist L, Palmqvist R, Rutegård M, Riklund K. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. Cancer Imaging 2019;19:52. [PMID: 31337428 DOI: 10.1186/s40644-019-0237-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
11 Ganeshan B, Miles K, Afaq A, Punwani S, Rodriguez M, Wan S, Walls D, Hoy L, Khan S, Endozo R, Shortman R, Hoath J, Bhargava A, Hanson M, Francis D, Arulampalam T, Dindyal S, Chen SH, Ng T, Groves A. Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer. Cancers (Basel) 2021;13:2715. [PMID: 34072712 DOI: 10.3390/cancers13112715] [Reference Citation Analysis]
12 Liang J, Zhang X, Miao Y, Li J, Gan Y. Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma. Int J Nanomedicine 2017;12:2033-44. [PMID: 28352173 DOI: 10.2147/IJN.S128525] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
13 Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A, Ludwig JM, Kirchner J, Rischpler C, Herrmann K, Catalano OA, Umutlu L. 18F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET? J Clin Med 2020;9:E3163. [PMID: 33003615 DOI: 10.3390/jcm9103163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lenga L, Lange M, Arendt CT, Booz C, Yel I, Bodelle B, D'angelo T, Hammerstingl RM, Huizinga NA, Vogl TJ, Martin SS, Albrecht MH. Measurement Reliability and Diagnostic Accuracy of Virtual Monoenergetic Dual-Energy CT in Patients with Colorectal Liver Metastases. Academic Radiology 2020;27:e168-75. [DOI: 10.1016/j.acra.2019.09.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
15 Crimì F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D, Pucciarelli S. [18F]FDG PET/MRI in rectal cancer. Ann Nucl Med 2021;35:281-90. [PMID: 33517562 DOI: 10.1007/s12149-021-01580-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Joo I, Lee JM, Yoon JH. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 2018;288:7-13. [DOI: 10.1148/radiol.2018171187] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 16.3] [Reference Citation Analysis]